Nasdaq:BBNX – SPAC Feed

Nasdaq:BBNX
US08659B1026

January 31, 2025

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today…

By sf-admin

Nasdaq:BBNX
TEMPISIN1234

January 29, 2025

Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering

IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the…

By sf-admin